Apr 1, 2026 | News, Press Review
Touchpoint, an editorial publication focused on the intersection between markets and innovation, dedicated a feature in its February–March print edition to Hemera, including an interview with Cristiana Vignoli, Chief Executive Officer of the company. The interview...
Mar 27, 2026 | News, Press Review
In January 2026, following the dissemination of the scientific preprint on the cell therapy REMaST published in the international scientific journal Immunity by Cell Press,Hemera received significant national media coverage, confirming the growing interest in...
Mar 23, 2026 | News, Press Review
Hemera is featured in an article published by Osservatorio Terapie Avanzate, a leading Italian editorial platform focused on scientific information and analysis of innovations in advanced therapies, regenerative medicine, and biotechnology. In the interview, Cristiana...
Mar 18, 2026 | Events, News
Hemera was selected to present its scientific and entrepreneurial journey at the European Deeptech Week in Paris, one of Europe’s leading events dedicated to scientific and technological innovation, organized by Bpifrance and co-hosted with European initiatives such...
Mar 15, 2026 | News, Videos
The research developed by Hemera was featured in the TG4 Medicina, an in-depth health and innovation program within the national news broadcast of Rete 4 dedicated to medical and scientific topics. The interview featured Ilaria Decimo, Co-Founder and Director of...
Mar 10, 2026 | News, Press Releases
The research of Hemera was featured on the Smart City podcast on Radio 24, dedicated to scientific and technological innovation, in an interview with Ilaria Decimo, co-founder and Director of Research & Development at Hemera. The episode addressed one of the most...